Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11113280 | 0.97 | FDPS (0.36) | FDPS | |
| SCHEMBL193494 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL6047554 | 0.90 | FDPS (0.36) | FDPS | |
| Iodide SCHEMBL6470624 | 0.90 | FDPS (0.36) | FDPS | |
| Hydrochloric Acid SCHEMBL28030431 | 0.90 | FDPS (0.36) | FDPS | |
| Iodide SCHEMBL6470625 | 0.90 | FDPS (0.36) | FDPS | |
| SCHEMBL4813773 | 0.90 | FDPS (0.36) | FDPS | |
| Iodide SCHEMBL7849929 | 0.90 | FDPS (0.36) | FDPS | |
| Bromide SCHEMBL11761277 | 0.90 | FDPS (0.36) | FDPS | |
| SCHEMBL11429095 | 0.88 | FDPS (0.39) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070144970-A1 | Supported zeolite membranes, their process for production and their applications | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-06-28 | — | — | US | claimed |
| US-20070043093-A1 | Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2007-02-22 | — | — | US | claimed |
| EP-1695968-A1 | THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, THE PREPARATION AND THE USE OF THE SAME | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2006-08-30 | — | — | EP | claimed |
| EP-0141371-B1 | SECONDARY BATTERY | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1988-08-10 | — | — | EP | claimed |
| CN-116617403-A | Amino acid modified ionic liquid and preparation method and application thereof | 北京大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-110382566-B | Modified conjugated diene polymer and rubber composition containing same | 株式会社LG化学 | 2022-08-12 | — | — | CN | disclosed |
| CN-114599697-A | Modified conjugated diene polymer, method for producing same, and rubber composition containing same | 株式会社LG化学 | 2022-06-07 | — | — | CN | disclosed |
| CN-114450319-A | Modified conjugated diene polymer, method for producing same, and rubber composition containing same | 株式会社LG化学 | 2022-05-06 | — | — | CN | disclosed |
| CN-109890851-B | Method for preparing modified conjugated diene polymer | 株式会社LG化学 | 2021-11-02 | — | — | CN | disclosed |
| CN-110167977-A | Conjugated diene polymer, conjugated diene polymer composition and tire | 日本弹性体株式会社 | 2019-08-23 | — | — | CN | disclosed |
| CN-110121513-A | Modified conjugated diene polymer and rubber composition containing same | 株式会社LG化学 | 2019-08-13 | — | — | CN | disclosed |
| CN-110121514-A | Modified conjugated diene polymer and rubber composition containing same | 株式会社LG化学 | 2019-08-13 | — | — | CN | disclosed |
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-05-18 | — | — | US | disclosed |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-04-07 | — | — | US | disclosed |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040092777-A1 | Method for producing allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| US-4201725-A | TRISUBSTITUTED METHYL-N-METHYLAMINE, PARKINSON*S DISEASE, ANTISPASMODIC AGENTS | LABAZ (FR) | 1980-05-06 | — | — | US | disclosed |
| US-4057644-A | PARKINSON'S DISEASE | LABAZ (FR) | 1977-11-08 | — | — | US | disclosed |
| US-4048334-A | PARKINSON*S DISEASE, NEUROLEPTIC AGENTS | LABAZ (FR) | 1977-09-13 | — | — | US | disclosed |
| US-4026925-A | PARKINSON*S DISEASE | LABAZ (FR) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | FDPS 150/4885 |
| US-20070043093-A1 | Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same | GLP1R, GCGR, GIPR | FDPS 2850/4885 |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | FDPS 150/4885 |
| US-20040092777-A1 | Method for producing allyl compound | CCNT1, APEX1, REV1 | FDPS 888/4885 |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | CCNT1, AOC3, ATL3 | FDPS 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.